Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative Review
Skin Appendage Disorders · 2024 · 10 (1) · 1-9
DOI: 10.1159/000533963 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Skin Appendage Disorders, online erschienen am 20.10.2023. Verfasst von Sophia Reyes-Hadsall und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Miami Miller School of Medicine, Miami, FL, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Acne is a chronic inflammatory disease of the pilosebaceous unit with a multifactorial etiology and is one of the most common conditions treated by dermatologists and primary care physicians. Within an extensive and evolving treatment landscape, oral isotretinoin has demonstrated efficacy for treatment of severe, recalcitrant acne. Several side effects of isotretinoin have been reported, including laboratory abnormalities, mucocutaneous, and musculoskeletal effects, which may reduce compliance and patient satisfaction with treatment. In this narrative review, we aim to review the efficacy and safety profile of oral supplements or topical adjuvant therapies in mitigating isotretinoin-associated mucocutaneous and musculoskeletal side effects. Oral supplements reviewed include omega-3 fatty acids, vitamin E, folic acid and vitamin B12, antihistamines, l-carnitine, biotin, and combined oral supplements. Topical adjuvants include a hyaluronic acid, biosaccharide gum-2, and glycerine gel-cream; a nongreasy, noncomedogenic, fragrance-free moisturizing cream; dexpanthenol; trichloroacetic acid; and a combination cream. Most of the supplements and topical adjuvants demonstrated efficacy with an adequate level of supporting evidence and no reported adverse events, indicating an adequate safety profile. Patients on isotretinoin may benefit from using oral supplements and topical adjuvants to minimize primarily mucocutaneous side effects, increase adherence to treatment, and thereby improve overall outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Miami Miller School of Medicine, Miami, FL, USA.
- Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, FL, USA.
Zitieren
APA
Reyes-Hadsall, S., Ju, T., & Keri, J. E. (2024). Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative Review. Skin Appendage Disorders, 10(1), 1-9. https://doi.org/10.1159/000533963
Vancouver
Reyes-Hadsall S, Ju T, Keri JE. Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative Review. Skin Appendage Disorders. 2024;10(1):1-9. doi:10.1159/000533963
BibTeX
@article{ReyesHadsall2024,
author = {Reyes-Hadsall, Sophia and Ju, Teresa and Keri, Jonette E},
title = {Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative Review},
journal = {Skin Appendage Disorders},
year = {2024},
volume = {10},
number = {1},
pages = {1--9},
doi = {10.1159/000533963}
}
EUVIMED